PERCEPTIVE ADVISORS LLC 13D and 13G filings for Iovance Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | PERCEPTIVE ADVISORS LLC | 22,112,266 7.300% | -4,505,443 (-16.93%) | Filing |
| 2024-11-14 4:50 pm Purchase | 2024-09-30 | 13G | Iovance Biotherapeutics, Inc. IOVA | PERCEPTIVE ADVISORS LLC | 26,617,709 8.800% | 7,395,966 (+38.48%) | Filing |
| 2024-03-01 7:09 pm Purchase | 2024-02-20 | 13G | Iovance Biotherapeutics, Inc. IOVA | PERCEPTIVE ADVISORS LLC | 19,221,743 6.900% | 7,242,328 (+60.46%) | Filing |
| 2024-02-14 4:29 pm Purchase | 2023-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | PERCEPTIVE ADVISORS LLC | 11,979,415 4.700% | 2,007,635 (+20.13%) | Filing |
| 2023-02-14 2:32 pm Sale | 2022-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | PERCEPTIVE ADVISORS LLC | 9,971,780 6.300% | -156,161 (-1.54%) | Filing |
| 2022-02-14 3:48 pm Purchase | 2021-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | PERCEPTIVE ADVISORS LLC | 10,127,941 6.500% | 961,637 (+10.49%) | Filing |
| 2021-02-16 3:33 pm Sale | 2020-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | PERCEPTIVE ADVISORS LLC | 9,166,304 6.300% | -245,092 (-2.60%) | Filing |